| Lantheus Holdings, Inc | $6.5b | $100.00 | -0.2% | 641.7K | |
| AbCellera Biologics Inc. Common Shares | $4.5b | $13.24 | -4.6% | 9.5M | |
| Immunome, Inc. | $2.4b | $19.39 | -8.8% | 2.2M | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.4b | $14.73 | -2.6% | 380.9K | |
| Aktis Oncology, Inc. Common stock | $1.0b | $17.82 | -3.7% | 262.7K | |
| Crescent Biopharma, Inc. Common Stock | $0.5b | $13.59 | -2.5% | 448.0K | |
| Perspective Therapeutics, Inc. | $315.1m | $2.39 | -7.0% | 2.6M | |
| Actinium Pharmaceuticals, Inc | $36.8m | $1.13 | -5.8% | 437.9K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.91 | 0.0% | N/A | |
| iTonic Holdings Ltd Class A Ordinary Shares | $29.1m | $4.04 | 0.0% | 82.2K | |
| American Shared Hospital Services | $9.4m | $1.39 | +2.2% | 4.7K |